'Hoax' Aids cure makes a fortune for Kenyan coterie

David Orr in Nairobi reports on scientific clashes over the mystery 'miracle' drug for HIV

It has both been hailed as a miracle cure for Aids and dismissed as a worthless hoax. The man behind the product, a University of London- educated doctor with influential connections in the Kenyan government, is variously known as a brilliant scientist or a commercial opportunist. What is certain is that his compound is making a fortune for a small coterie of people able to flout the law with impunity.

Pearl Omega first hit the Kenyan headlines earlier this year with claims by Professor Arthur Obel, a high-ranking government employee, that he had discovered a cure for Aids. He said the drug had restored the health of seven Aids patients since trials began in 1991.

However, having produced no scientific data to back up his assertions, the doctor, aged 56, soon found himself under attack from Kenya's medical establishment. Even President Daniel arap Moi intervened to say there was no known cure for the epidemic.

More recently, Professor Obel has attracted attention by dismissing as useless AZT, the foremost Aids management drug, and by claiming that condoms being exported from Britain were laced with the HIV virus. "Pearl Omega is still at an experimental stage," Professor Obel told the Independent in a telephone interview. "But it has had no untoward effects on anyone and the government has validated it.

"I have patients from all around the world, including the UK. The problem is that Pearl Omega is being sold on the black market by unscrupulous doctors.

"I'm even having difficulties with medical colleagues. I give them samples to analyse and they sell it to people without my permission."

What Professor Obel failed to say was that he himself has illegally been selling the product. Under Kenyan law, any new drug must be analysed and approved by the ministry of health before it can be put on the market. Yet, despite the fact that no licence has been issued for the sale and distribution of Pearl Omega, bottles of the herbal potion are being sold at the professor's International Medical Foundation and at the government- sponsored Biodiversity Centre in the capital, Nairobi. Professor Obel says his discovery will be registered today.

Professor Obel and Pearl Omega have received the fullest backing of the Kenyan government. The Biodiversity Centre which produces Pearl Omega has received substantial government money to produce the compound. Professor Obel, who goes by the title of chief government scientist in the Office of the President, is at all times accompanied by armed government security guards.

A carton of the product contains 12 bottles and retails for 30,000 Kenyan shillings (pounds 350). Professor Obel says it is being produced in large quantities and has been used to treat many patients infected with HIV.

An International Medical Foundation employee told the Independent that Pearl Omega was a "guaranteed" Aids cure. She added that, if a person had been sick for a long time, two doses would be required.

Further attempts to get information about the concoction have proved difficult. Professor Obel, who had agreed to meet the Independent, failed to turn up at the appointed venue. He later said he had received "directives" not to give interviews.

Kenya's medical establishment has also had difficulties in acquiring information on Pearl Omega. Professor Obel has consistently refused to produce the scientific data needed to verify what he calls the "astounding" properties of his agent. Neither has he come forward with samples for analysis. Protocol demands the samples be submitted directly by the producer.

"Obel has not succeeded in convincing us as to the efficacy of Pearl Omega," said Professor Peter Odhiambo, Dean of the Faculty of Medicine at Nairobi University and a former colleague of the professor.

"We have a right to know what procedures were followed during research but so far we've seen no evidence."

Professor Odhiambo said one bottle of Pearl Omega shown to him had smelt strongly of alcohol while another had smelt strongly herbal. He said a considerable amount of the compound was in circulation because Aids patients were dying before they could finish the 12-bottle course.

"Pearl Omega has not been certified by the government," said Dr Richard Barasa, chairman of the Medical Practitioners and Dentists Board, Kenya's professional licensing board. "If it's being used, it's being prescribed illegally."

So incensed has the board become with Professor Obel's behaviour that it is looking at deregistering him. If it does, Professor Obel will no longer be allowed to practise medicine in Kenya.

"This man is bringing the medical profession into disrepute," said Dr Barasa. "And it is not for the first time."

Professor Obel was involved with the development of Kemron, another supposedly miraculous Aids management drug, in the late 1980s.

Much touted at the time, the product was later discredited. Professor Obel is believed to have made considerable profits from its sale. His detractors say his development of Pearl Omega is likely to bring similar riches.

Start your day with The Independent, sign up for daily news emails
election 2015The 10 best quotes of the campaign
A caravan being used as a polling station in Ford near Salisbury, during the 2010 election
election 2015The Independent's guide to get you through polling day
David Blunkett joins the Labour candidate for Redcar Anna Turley on a campaigning visit last month
voicesWhat I learnt from my years in government, by the former Home Secretary David Blunkett
Have you tried new the Independent Digital Edition apps?
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Ashdown Group: Marketing Manager (B2B) - Romford - £40,000 + car

£35000 - £40000 per annum + car and benefits: Ashdown Group: Marketing Manager...

Ashdown Group: Helpdesk Analyst - Devon - £20,000

£18000 - £20000 per annum: Ashdown Group: Helpdesk Analyst - Devon - £20,000 ...

Ashdown Group: Data Scientist - London - £50,000 + bonus

£35000 - £50000 per annum + generous bonus: Ashdown Group: Business Analytics ...

Ashdown Group: IT Project Coordinator (Software Development) - Kingston

£45000 - £50000 per annum: Ashdown Group: IT Project Coordinator (Software Dev...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
The Pan Am Experience is a 'flight' back to the 1970s that never takes off - at least, not literally

Pan Am Experience: A 'flight' back to the 70s

Tim Walker checks in and checks out a four-hour journey with a difference
Humans aren't alone in indulging in politics - it's everywhere in the animal world

Humans aren't alone in indulging in politics

Voting, mutual back-scratching, coups and charismatic leaders - it's everywhere in the animal world
Crisp sales are in decline - but this tasty trivia might tempt back the turncoats

Crisp sales are in decline

As a nation we're filling up on popcorn and pitta chips and forsaking their potato-based predecessors
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
Barcelona 3 Bayern Munich 0 player ratings: Lionel Messi scores twice - but does he score highest in our ratings?

Barcelona vs Bayern Munich player ratings

Lionel Messi scores twice - but does he score highest in our ratings?
Martin Guptill: Explosive New Zealand batsman who sets the range for Kiwis' big guns

Explosive batsman who sets the range for Kiwis' big guns

Martin Guptill has smashed early runs for Derbyshire and tells Richard Edwards to expect more from the 'freakish' Brendon McCullum and his buoyant team during their tour of England
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'